U.S. Physical Therapy, Inc. USPH
98.07 USD -1.77 (-1.77%)
Nov 10, 2026, 10:53 AM EST
96.86 Day range 99.67
59.00 52-week range 99.84
- YTD
- +25.59%
- 1 year
- +33.79%
News
marketbeat.com U.S. Physical Therapy Q3 Earnings Call Highlights U.S. Physical Therapy NYSE: USPH reported double-digit revenue and EBITDA growth for the third quarter of 2026 as higher patient volumes and reimbursement rates from hospital affiliations helped…
benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $110 Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $98 to $110.
defenseworld.net U.S. Physical Therapy (NYSE:USPH) Hits New 52-Week High Following Earnings Beat U.S. Physical Therapy, Inc. (NYSE: USPH - Get Free Report)'s stock price reached a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company…
benzinga.com US Physical Therapy Q3 2026 Earnings Call Transcript US Physical Therapy (NYSE:USPH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Here's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q3 Earnings While the top- and bottom-line numbers for U.S. Physical Therapy (USPH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its…
zacks.com U.S. Physical Therapy (USPH) Tops Q3 Earnings and Revenue Estimates U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.66 per share a year ago.
benzinga.com US Physical Therapy Q3 Adj. EPS $0.80 Beats $0.76 Estimate, Sales $222.558M Beat $214.536M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.76 by 5.26 percent. This is a 21.21 percent increase over earnings of…
businesswire.com USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury…
benzinga.com Transcript: US Physical Therapy Q2 2026 Earnings Conference Call On Thursday, US Physical Therapy (NYSE:USPH) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga…- benzinga.com JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95 JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.
- benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98 Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $90 to $98.
benzinga.com US Physical Therapy Q2 Adj. EPS $0.75 Misses $0.84 Estimate, Sales $214.059M Beat $211.307M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.75 per share which missed the analyst consensus estimate of $0.84 by 10.71 percent. This is a 7.41 percent decrease over earnings of…
benzinga.com U.S. Physical Therapy Acquires Majority Stake In Twelve-Clinic Physical Therapy Practice; Financial Terms Undisclosed U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today- benzinga.com Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target Citizens analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $98 price target.
- benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90 Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $103 to $90.
- benzinga.com Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98 Citizens analyst Constantine Davides maintains US Physical Therapy (NYSE:USPH) with a Market Outperform and lowers the price target from $113 to $98.
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com US Physical Therapy Q1 Adj. EPS $0.46 Misses $0.55 Estimate, Sales $198.286M Miss $201.007M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.55 by 16.36 percent. This is a 4.17 percent decrease over earnings of…
- benzinga.com US Physical Therapy Secures $450M Credit Deal, Extends Debt Maturity To 2031 With Larger Loan And Revolver Package U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today…
benzinga.com US Physical Therapy Q4 Adj. EPS $0.67, Inline, Sales $202.726M Beat $200.425M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.67 per share which met the analyst consensus estimate. This is a 31.37 percent increase over earnings of $0.51 per share from the…- benzinga.com Earnings Scheduled For February 25, 2026
benzinga.com Exploring US Physical Therapy's Earnings Expectations - benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
- benzinga.com U.S. Physical Therapy Acquires Undisclosed Industrial Injury Prevention Business For ~$15.1M U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services,…
- benzinga.com U.S. Physical Therapy Signs 10-Year Alliance With NYU Langone Health To Collaborate Together In Long Island, New York Metropolitan Area To Provide Physical Therapy To Patients U.S. Physical Therapy, Inc. ("USPH") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced a 10-year…
benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.- benzinga.com U.S. Physical Therapy Acquires 50% Stake In Unnamed Physical Therapy Management Services Firm; Financial Terms Not Disclosed U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services,…
- benzinga.com JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $100 JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $110 to $100.
benzinga.com US Physical Therapy Q3 Adj. EPS $0.66 Misses $0.67 Estimate, Sales $197.132M Beat $193.961M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.67 by 1.49 percent. This is a 4.35 percent decrease over earnings of…
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com JP Morgan Assumes US Physical Therapy at Overweight, Announces Price Target of $110 JP Morgan analyst Benjamin Rossi assumes US Physical Therapy (NYSE:USPH) with a Overweight rating and announces Price Target of $110.- benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $103 Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $98 to $103.
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com US Physical Therapy Q2 Adj. EPS $0.81 Beats $0.71 Estimate, Sales $197.344M Beat $189.602M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.81 per share which beat the analyst consensus estimate of $0.71 by 13.29 percent. This is a 10.96 percent increase over earnings of…- benzinga.com Earnings Scheduled For August 6, 2025
- benzinga.com Price Over Earnings Overview: US Physical Therapy
- benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Maintains $98 Price Target Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $98 price target.
- benzinga.com US Physical Therapy Q1 Adj. EPS $0.48 Beats $0.43 Estimate, Sales $183.79M Beat $177.25M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.43 by 11.63 percent. This is a 5.88 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com U.S. Physical Therapy Acquires Outpatient Home Care Physical and Speech Therapy Practice For Undisclosed Terms U.S. Physical Therapy, Inc. (the Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of…
- benzinga.com JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target JMP Securities analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $113 price target.
- benzinga.com JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $110 JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $120 to $110.
- benzinga.com What Analysts Are Saying About US Physical Therapy Stock
- benzinga.com Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $98 Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $108 to $98.
- benzinga.com US Physical Therapy Q4 Adj $0.51 Misses $0.69 Estimate, Sales $180.45M Beat $174.77M Estimate US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.69 by 26.09 percent. This is a 13.56 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For February 26, 2025
- benzinga.com US Physical Therapy Positioned For Success Despite Medicare Challenges, Analyst Optimistic On Unique Growth Strategy JMP Securities initiates U.S. Physical Therapy (USPH) coverage with a $113 target, citing growth driven by acquisitions, partnerships, and strategic focus.
- benzinga.com This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- benzinga.com B of A Securities Upgrades US Physical Therapy to Buy, Raises Price Target to $115 B of A Securities analyst Joanna Gajuk upgrades US Physical Therapy (NYSE:USPH) from Neutral to Buy and raises the price target from $100 to $115.
- benzinga.com JMP Securities Initiates Coverage On US Physical Therapy with Market Outperform Rating, Announces Price Target of $113 JMP Securities analyst Constantine Davides initiates coverage on US Physical Therapy (NYSE:USPH) with a Market Outperform rating and announces Price Target of $113.